Act now: incentives & strategies to drive innovation in the antimicrobial resistance market

Dr. Lesley Ogilvie, Interim Secretariat Lead of the Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub, gave a presentation at a digital conference hosted by Informa Connect on the 2nd of November titled Act now: incentives & strategies to drive innovation in the AMR market.

The session was titled Supporting evidence-based decision making across the AMR research and development value chain and explored the following:

  • What is the current state of public funding for AMR R&D globally?
  • Is this funding being translated into products that mitigate AMR?
  • What are governments doing to incentivize development and access to priority antimicrobials?

The full agenda can be found here and information about the digital conference speakers can be found here.

Curious about more?

You can sign up for our newsletter here. By subscribing, you automatically provide your consent for the use of your data in accordance with our privacy policy.

This field is for validation purposes and should be left unchanged.

Latest news

Go to all news
Dynamic Dashboard